Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q1 2016 Earnings

29FebConfirmed

Q2 2015

Q3 2015

Q4 2015

Q1 2016

-0.19

-0.12

-0.04

0.03

Details

Expected EPS

-0.05

Actual EPS

0.03

Surprise EPS

0.08

Surprise Percent

+160%

Description

Halozyme Therapeutics (HALO) has reported earnings of 0.03 per share for Q1 2016.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.